14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
PRE vs SENEB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
SENEB Overall Winner
6-Pillar Tally: PRE 0 – 6 SENEB
Matrix Metrics: PRE 2 – 8 SENEB
As of Nov 16, 2026, SENEB (SENEB) is the stronger overall head-to-head candidate over Prenetics Global Limited Class A Ordinary Share (PRE) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PRE carries a Unified Composite Score of 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin), whereas SENEB carries 54.4/100 (HOLD) at $170.26 (48.1x Forward P/E, 8.9% operating margin).
Growth vs. Quality Trade-Off: SENEB earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. PRE 49.8/100 HOLD) and 0.10β · 88% Vol risk profile, whereas PRE leads top-line expansion (+210.7% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: PRE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1); meanwhile SENEB trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRE vs SENEB. Trailing 12-month operating profitability (PRE -34.6% vs SENEB 8.9%) and valuation multiples (PRE N/M vs SENEB 48.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Packaged Foods value chain with $1.2B market capitalization and 8.9% operating margin.
OpEx & R&D Reinvestment4.3% of Rev ($77M)
90D Engineering Disclosures0 Published
Investor FAQ PRE vs SENEB Key Questions & Quantitative Answers
As of Nov 16, 2026, SENEB (SENEB) is the stronger overall head-to-head candidate over Prenetics Global Limited Class A Ordinary Share (PRE) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PRE carries a Unified Composite Score of 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin), whereas SENEB carries 54.4/100 (HOLD) at $170.26 (48.1x Forward P/E, 8.9% operating margin). Growth vs. Quality Trade-Off: SENEB earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. PRE 49.8/100 HOLD) and 0.10β · 88% Vol risk profile, whereas PRE leads top-line expansion (+210.7% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: PRE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1); meanwhile SENEB trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SENEB leads the Growth & Scale pillar: PRE posts +210.7% YoY revenue growth and +0.0% YoY earnings growth on $155M TTM revenue (57.8% gross margin, -34.6% operating margin), compared with SENEB at +7.1% YoY revenue growth and -0.4% YoY earnings growth on $1.80B TTM revenue (13.2% gross margin, 8.9% operating margin). On trailing 12-month operating scale, PRE generates $155M in USD-normalized revenue versus $1.80B for SENEB. In operating R&D and SG&A reinvestment, PRE deploys N/A (0 90-day corporate R&D disclosures) versus 4.3% of Rev ($77M) (0 disclosures) for SENEB.
SENEB screens cheaper on headline valuation multiples. PRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (-34.9% EBITDA margin), whereas SENEB trades at 48.1x Forward P/E, 10.0x Trailing P/E, 0.94x PEG, and 0.6x EV/Revenue (11.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PRE (-47.0% ROE) versus SENEB (16.1% ROE) capital efficiency.
In options market volatility and institutional positioning, PRE carries 124.1% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.63β · 74% Vol realized risk). By comparison, SENEB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.10β · 88% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.